Ensign Peak Advisors, Inc
Position in IDYA — IDEAYA Biosciences, Inc.
CIK 1454984
SALT LAKE CITY, UT
Position in IDYA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$9,957,873
-$20,013,600 QoQ
Shares Held
267,182
-70.3% QoQ
Ownership
0.277%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#51
of 286 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in IDYA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,119,129,230 across 124 Biotechnology names. IDYA ranks #32 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in IDYA
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $9,957,873 | 267,182 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $29,971,473 | 899,504 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $33,846,207 | 979,063 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $20,493,592 | 753,164 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $15,593,329 | 741,833 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $5,366,808 | 327,644 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $14,500,376 | 564,217 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,382,267 | 611,814 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $16,983,198 | 483,714 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $21,429,675 | 488,370 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $17,435,587 | 490,039 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $9,814,892 | 363,784 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $5,485,699 | 233,434 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,268,803 | 92,411 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,679,107 | 92,411 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,494,551 | 100,171 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,307,977 | 94,781 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,060,599 | 94,781 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $2,184,596 | 92,411 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $940,963 | 36,915 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $774,845 | 36,915 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $867,502 | 36,915 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $516,810 | 36,915 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $463,652 | 36,915 | Shares | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||